CAR T Cell Membrane Camouflaged Nanocatalyst Augments CAR T Cell Therapy Efficacy Against Solid Tumor
Small · 2024-09 · 20 (37)
DOI: 10.1002/smll.202401299 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 15.05.2024. Verfasst von Wenjing Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Molecular Sciences, Wuhan University, Wuhan, 430072, P. R. China. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Immunotherapy, Adoptive, Cell Membrane. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China National Postdoctoral Program for Innovative Talents, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
The immunosuppressive tumor microenvironment (TME) reduces the chimeric antigen receptor (CAR) T‐cell therapy against solid tumors. Here, a CAR T cell membrane‐camouflaged nanocatalyst (ACSP@TCM) is prepared to augment CAR T cell therapy efficacy against solid tumors. ACSP@TCM is prepared by encapsulating core/shell Au/Cu 2‐ x Se and 3‐bromopyruvate with a CAR T cell membrane. It is demonstrated that the CAR T cell membrane camouflaging has much better‐targeting effect than the homologous tumors cell membrane camouflaging. ACSP@TCM has an appealing synergistic chemodynamic/photothermal therapy (CDT/PTT) effect that can induce the immunogenic cell death (ICD) of NALM 6 cells. Moreover, 3‐bromopyruvate can inhibit the efflux of lactic acid by inhibiting the glycolysis process, regulating the acidity of TME, and providing a more favorable environment for the survival of CAR T cells. In addition, the photoacoustic (PA) imaging and computed tomography (CT) imaging performance can guide the ACSP@TCM‐mediated tumor therapy. The results demonstrated that the ACSP@TCM significantly enhanced the CAR T cell therapy efficacy against NALM 6 solid tumor mass, and completely eliminated tumors. This work provides an effective tumor strategy for CAR T cell therapy in solid tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chemistry and Molecular Sciences, Wuhan University, Wuhan, 430072, P. R. China.
- Department of Orthopedics Trauma and Microsurgery, School of Pharmaceutical Sciences, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, 430071, P. R. China.
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc…
- Tianjin Institutes of Health Science, Tianjin, 301600, P. R. China.
- School of Chemical and Environmental Engineering, Wuhan Polytechnic University, Wuhan, 430023, P. R. China.
- Hubei Key Laboratory of Radiation Chemistry and Functional Materials School of Nuclear Technology and Chemistry and Biology, Hubei University of Science and Technology, Xianning, 437100, China.
ORCID-Profile: Peng Jiang
Förderung
- National Natural Science Foundation of China
- China National Postdoctoral Program for Innovative Talents
- China Postdoctoral Science Foundation
- Program of Science and Technology Plan of the City of Tianjin
Zitieren
APA
Wu, W., Li, H., Chen, W., Hu, Y., Wang, Z., She, W., Huang, L., Liu, Y., & Jiang, P. (2024). CAR T Cell Membrane Camouflaged Nanocatalyst Augments CAR T Cell Therapy Efficacy Against Solid Tumor. Small, 20(37). https://doi.org/10.1002/smll.202401299
Vancouver
Wu W, Li H, Chen W, Hu Y, Wang Z, She W, et al. CAR T Cell Membrane Camouflaged Nanocatalyst Augments CAR T Cell Therapy Efficacy Against Solid Tumor. Small. 2024;20(37). doi:10.1002/smll.202401299
BibTeX
@article{Wu2024,
author = {Wu, Wenjing and Li, Haimei and Chen, Wenqi and Hu, Yulin and Wang, Zichen and She, Wenyan and Huang, Liang and Liu, Yi and Jiang, Peng},
title = {CAR T Cell Membrane Camouflaged Nanocatalyst Augments CAR T Cell Therapy Efficacy Against Solid Tumor},
journal = {Small},
year = {2024},
volume = {20},
number = {37},
doi = {10.1002/smll.202401299}
}
EUVIMED